Latest filing published 04 May 2021 for Werewolf Therapeutics, Inc., €3.3M.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -66.1%Entry US$15.91 · Close at T+365 US$5.40
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Longwood Fund III GP, LLC: trading record in brief
Longwood Fund III GP, LLC appears in our data through filings on Werewolf Therapeutics, Inc. shares, published by SEC (Form 4). We count 3 filings, every one of them for a trade on 4 May 2021.
No open-market sale appears; the market trades are 1 purchase worth €3.3M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The latest filing, published on 4 May 2021, reports an open-market purchase of €3.3M in Werewolf Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Longwood Fund III GP, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 250,000 shares@ US$16.00100.0% of flowCommon StockSEC:0000899243-21-018115:2Canonical exit: 2 Aug 2021 (T+90)
- 355,955 sharesCommon StockSEC:0000899243-21-018115:1
- 1,071,127 sharesCommon StockSEC:0000899243-21-018115:0
3 of 3 declarations
